ProShare Advisors’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$21.2K	Buy	+14,297	New	+$21.2K	﹤0.01%	2066
2024 Q2	–	Sell	-12,147	Closed	-$15.3K	–	1963
2024 Q1	$15.3K	Buy	12,147 +1,168	+11%	+$1.47K	﹤0.01%	1981
2023 Q4	$19.5K	Buy	+10,979	New	+$19.5K	﹤0.01%	1920